Biohub Discovery: Common Amino Acid "Cocktail" Boosts mRNA Delivery 20-Fold and Propels CRISPR Gene Editing Efficiency to 90 Percent

Biohub researchers find that adding three amino acids to LNP injections increases mRNA delivery 20-fold and achieves 90% CRISPR gene editing efficiency.

By: AXL Media

Published: Mar 13, 2026, 7:10 AM EDT

Source: Information for this report was sourced from Biohub

Solving the Physiological Bottleneck of LNP Delivery

Lipid nanoparticles (LNPs) are the primary vehicles for the global mRNA revolution, yet their performance in the human body has consistently lagged behind laboratory results. While billions of dollars have been spent redesigning the nanoparticles themselves, a team at Biohub led by Drs. Daniel Zongjie Wang and Shana O. Kelley shifted the focus to the cells receiving the cargo. Their study, published in Science Translational Medicine, reveals that the "physiological milieu" of the human body essentially puts cells on a lean metabolic diet that hampers their ability to internalize LNPs. By addressing the cell's metabolic state rather than the nanoparticle's chemistry, the team has provided a universal solution to a stubborn medical bottleneck.

Identifying the Metabolic Roadblock in Human Plasma

The breakthrough came from a comparison of standard laboratory cell culture media and a specialized medium that mimics human plasma. Researchers found that LNP uptake plummeted by 50 to 80 percent in the plasma-like environment. Sophisticated genetic and metabolic analyses pinpointed the culprit: several amino acid pathways are significantly suppressed in the body compared to the nutrient-rich environments of a lab dish. This suppression "narrows the door" through which nanoparticles enter cells. To counteract this, the team developed an optimized supplement of methionine, arginine, and serine that re-activates these pathways and coaxes cells into a high-uptake state.

A 20-Fold Surge in mRNA Therapeutic Efficacy

The impact of this amino acid cocktail was demonstrated across intramuscular, intratracheal, and intravenous administration routes. In every case, protein expression increased 5- to 20-fold, regardless of the specific lipid formulation or mRNA cargo used. To test the clinical potential, the researchers applied the supplement to a mouse model of acute liver failure—the leading cause of drug-induced liver death in humans. While LNPs alone resulted in only a 33 percent survival rate, pairing the treatment with the amino acid cocktail resulted in a 100 percent survival rate. Furthermore, markers of liver inflammation and damage dropped to near-healthy levels, proving the therapy’s potent restorative power.